Korea seeks to become world’s top biopharmaceutical manufacturer by 2030
Chief among the next-generation growth drivers will be biopharmaceutical manufacturing, bioenergy, new biomaterials development and digital bioenergy ecosystem establishment. Korea will seek to achieve bio-related economic production of 100 trillion won ($79 billion) and increase biopharmaceutical exports to $50 billion by 2030, the industry ministry said Wednesday. Chief among the next-generation growth drivers will be biopharmaceutical manufacturing, bioenergy, new…